Paper42882002PubMed
MetALD in Clinical Practice: Diagnosis, Non-Invasive Risk Stratification, and Management.
Krzewiński H and 2 others. J Clin Med, 2026.
Cite this record
ConductScience Library. MetALD in Clinical Practice: Diagnosis, Non-Invasive Risk Stratification, and Management. Papers, record 42882002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42882002
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MetALD in Clinical Practice: Diagnosis, Non-Invasive Risk Stratification, and Management.
- Journal
- J Clin Med
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-20
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References93
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39152050 | Cardiovascular disease assessment and management in liver transplantation. | Eur Heart J | 2024 | https://conductscience.org/library/papers/39152050 | PubMed |
| 2 | 41899181 | Alcohol Abstinence Is Associated with Regression of Non-Invasive Fibrosis Markers in Patients with Metabolic Syndrome: A 12-Month Prospective Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/41899181 | PubMed |
| 3 | 38851997 | EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). | J Hepatol | 2024 | https://conductscience.org/library/papers/38851997 | PubMed |
| 4 | 37364790 | A multisociety Delphi consensus statement on new fatty liver disease nomenclature. | J Hepatol | 2023 | https://conductscience.org/library/papers/37364790 | PubMed |
| 5 | 35120736 | Baveno VII - Renewing consensus in portal hypertension. | J Hepatol | 2022 | https://conductscience.org/library/papers/35120736 | PubMed |
| 6 | 17916548 | Assessment of hepatic fibrosis with magnetic resonance elastography. | Clin Gastroenterol Hepatol | 2007 | https://conductscience.org/library/papers/17916548 | PubMed |
| 7 | 26542285 | Adipocyte lipolysis and insulin resistance. | Biochimie | 2016 | https://conductscience.org/library/papers/26542285 | PubMed |
| 8 | 39996356 | Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. | Diabetes Obes Metab | 2025 | https://conductscience.org/library/papers/39996356 | PubMed |
| 9 | 37868808 | Alcohol-induced liver injury in signalling pathways and curcumin's therapeutic potential. | Toxicol Rep | 2023 | https://conductscience.org/library/papers/37868808 | PubMed |
| 10 | 39362716 | Diagnosis of Alcohol Use Disorder and Alcohol-Associated Liver Disease. | Clin Liver Dis | 2024 | https://conductscience.org/library/papers/39362716 | PubMed |
| 11 | 22563376 | Effects of ethanol and acetaldehyde on tight junction integrity: in vitro study in a three dimensional intestinal epithelial cell culture model. | PLoS One | 2012 | https://conductscience.org/library/papers/22563376 | PubMed |
| 12 | 41812830 | Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. | Gastroenterology | 2026 | https://conductscience.org/library/papers/41812830 | PubMed |
| 13 | 41728070 | MetALD: decoding the evolution of steatotic liver disease nomenclature and implications for clinical practice and beyond. | Gastroenterol Rep (Oxf) | 2026 | https://conductscience.org/library/papers/41728070 | PubMed |
| 14 | 41459093 | Metabolic dysfunction and alcohol-associated liver disease (MetALD). | eGastroenterology | 2025 | https://conductscience.org/library/papers/41459093 | PubMed |
| 15 | 20180235 | Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. | World J Gastroenterol | 2010 | https://conductscience.org/library/papers/20180235 | PubMed |
| 16 | 40832962 | Serum fibrosis scores as predictors of liver fibrosis and long-term outcomes in metabolic dysfunction-associated steatotic liver disease, including cirrhosis. | Rev Invest Clin | 2025 | https://conductscience.org/library/papers/40832962 | PubMed |
| 17 | 38174913 | ACG Clinical Guideline: Alcohol-Associated Liver Disease. | Am J Gastroenterol | 2024 | https://conductscience.org/library/papers/38174913 | PubMed |
| 18 | 28407655 | EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version). | Ultraschall Med | 2017 | https://conductscience.org/library/papers/28407655 | PubMed |
| 19 | 33588101 | Transient Elastography Accurately Screens for Compensated Advanced Chronic Liver Disease in Patients With Ongoing or Recent Alcohol Withdrawal. | Clin Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/33588101 | PubMed |
| 20 | 38858523 | Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. | Nat Med | 2024 | https://conductscience.org/library/papers/38858523 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42882002
GET https://conductscience.org/api/papers/v1/42882002/references?page=2